Instagram post (direct link, archive link) shows a syringe extracting fluid from a vial and claims a cure has been developed ...
Psychedelic industry faced setbacks, cannabis was almost rescheduled and overdose deaths dropped — but not for all ...
That's the title that Science magazine is bestowing upon the medication called lenacapavir — a twice yearly injectable that ...
RA and HIV PrEP successes, to flops in DMD and Alzheimer’s, Clinical Trials Arena rounds up the biggest trial read outs of ...
Science magazine has chosen twice-yearly lenacapavir PrEP as its 2024 Breakthrough of the Year, recognizing it as a ...
Gilead is going to start testing a drug it believes could prevent HIV infection with just a single shot every year.
This drug helps manage infections and prevent AIDS, but claims it’s a ‘cure’ are not supported
Though the post doesn’t specify, the two shots per year for HIV treatment that costs around $40,000 may refer to the injectable drug lenacapavir. The Food and Drug Administration approved lenacapavir ...
While the efficacy of twice-yearly subcutaneous lenacapavir for HIV prevention has previously been demonstrated in cisgender ...
Lenacapavir, a preventive HIV drug, could become accessible in low-income countries by 2026. Efforts spearheaded by global ...
By 2025, a new HIV preventive drug, lenacapavir, could be available to the world's poorest regions. The Global Fund aims to ...
Investors are bullish on Gilead as the stock surges on successful launches and strong financial health, offering potential ...
The post appears to reference the drug lenacapavir, which reportedly can cost around $40,000 annually in the U.S. and is administered in twice-yearly doses. While the drug appears to be effective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback